• Rebamipide, EP4, and Hair Regeneration

  2026-10-06

  Feng et al. report that rebamipide promotes hair regeneration by remodeling lipid metabolism in dermal adipocytes through EP4-linked signaling, autophagy, and ATGL-mediated lipolysis. The study connects adipocyte plasticity with PDGF-dependent activation of hair follicle stem cells, while also defining important boundaries around the evidence, which remains preclinical and mechanistic.

• MRT68921 and ULK1/2: Evidence and Research Context

  2026-10-05

  MRT68921 is a preclinical dual ULK1/2 kinase inhibitor used to investigate autophagy initiation. This overview compares supplier-reported mechanistic evidence with findings from a 2025 Atlantic salmon cell study, explains potential research applications, and defines limitations involving selectivity, model systems, pharmacological interpretation, and the absence of animal or clinical validation.

• Hematoxylin and Eosin Staining Kit Overview

  2026-10-05

  A concise, source-limited overview of APExBIO’s Hematoxylin and Eosin Staining Kit (SKU K1142), covering its documented identity, conceptual scope, and evidence limitations.

• AP20187: Context, Applications, and Evidence Limits

  2026-10-04

  AP20187 is a chemical inducer of dimerization used in engineered conditional signaling systems. This overview separates supplier-described applications from peer-reviewed evidence, explains its conceptual research value, and shows why findings on senescent cancer-associated fibroblasts should not be interpreted as direct validation of AP20187.

• CerS6, Ceramide, and EDTA-Free Protease Inhibitors

  2026-10-03

  A source-grounded overview of how stress-related CerS6 and C16:0 ceramide may contribute to hepatocyte mitochondrial injury, what the 2024 rat and cell study established, and where an EDTA-free protease inhibitor cocktail may fit conceptually in protein-focused analyses without extending the evidence beyond the published work.

• Protease Inhibitor Cocktail: Assay Reliability

  2026-10-01

  Learn how Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), SKU K1007, can reduce proteolysis-related variability in protein endpoints linked to viability, proliferation, and cytotoxicity studies. This scenario-based guide covers compatibility, dilution, interpretation, and practical vendor selection without confusing lysate preservation with direct effects on live-cell assay biology.

• WY-14643: PPARα Workflows for Liver Research

  2026-10-01

  Build reproducible PPARα experiments that connect lipid metabolism regulation with inflammatory and pyroptosis readouts. This practical guide shows how WY-14643 (Pirinixic Acid) can support endothelial, metabolic, and cholestatic liver models while addressing dosing, solubility, and interpretation risks.

• Aprotinin (BPTI): Mechanism and Research Use

  2026-10-01

  Aprotinin, or bovine pancreatic trypsin inhibitor (BPTI), is a reversible serine protease inhibitor that targets trypsin, plasmin, and kallikrein. Its fibrinolysis inhibition supports research on perioperative blood loss reduction and cardiovascular surgery blood management, while assay-specific potency, formulation behavior, and clinical safety history require careful interpretation.

• ML133 HCl: Kir2.1 Research Workflow

  2026-09-30

  ML133 HCl is a selective potassium channel inhibitor for separating Kir2.1-dependent effects from broader potassium-channel activity. Its strongest applied use is mechanistic pulmonary artery smooth muscle cell proliferation research, where pharmacology can be paired with migration, protein-expression, and signaling assays.

• PX-478 2HCl: HIF-1α Workflow & Applications

  2026-09-29

  PX-478 2HCl provides a chemically timed way to suppress HIF-1α across paired normoxic and hypoxic assays, with practical value in cancer-cell signaling, radiosensitization, and ischemia-reporter studies. A 2024 prenatal-hypoxia study also shows how the inhibitor can connect molecular readouts with behavioral and tissue-level outcomes, while emphasizing timing-dependent safety evaluation.

• Protease Inhibitor Cocktail for Wnt Workflows

  2026-09-29

  Protect Wnt receptor-complex samples from rapid proteolysis without introducing EDTA that can disrupt divalent-cation-sensitive assays. This workflow shows how an EDTA-free 100X DMSO formulation supports lysate preparation, co-immunoprecipitation, phosphorylation analysis, and kinase assay development.

• Protease Inhibitor Cocktail for Signaling Assays

  2026-09-28

  Learn how a Protease Inhibitor Cocktail improves protein degradation prevention and strengthens interpretation of bioenergetic, ER-stress, Western blot, and co-immunoprecipitation assays. This article translates findings from a ciclopirox NSCLC study into practical sample-preservation decisions.

• SARS-CoV-2 Variant Shifts in ACE2 Receptor Use

  2026-09-28

  Shukla and colleagues developed a barcoded pseudovirus assay to compare how six SARS-CoV-2 spike proteins use a multiplexed library of 30 ACE2 sequences. Their results show that variant-associated changes have modest effects on human ACE2 compatibility but can substantially alter compatibility with animal orthologs, highlighting the value of testing host and viral sequence variation together.

• AZ505: A Selective SMYD2 Inhibitor for Research

  2026-09-27

  AZ505 is a substrate-competitive SMYD2 inhibitor that blocks access to the enzyme’s peptide-substrate groove without competing with SAM. Product information reports biochemical potency and selectivity, while a cisplatin-induced kidney disease study provides preclinical evidence that pharmacological SMYD2 inhibition can reduce renal fibrosis and inflammation.

• PFHxS Disrupts Zebrafish Lipid Homeostasis via PPARα

  2026-09-26

  An integrated lipidomic and transcriptomic study found that environmentally relevant PFHxS exposures altered multiple lipid classes and PPAR-related pathways in zebrafish larvae. Molecular simulation and antagonist coexposure support PPARα as a potential initiating target, while the evidence does not establish it as the sole cause of the observed lipid changes.

8436 records 3/563 page Previous Next 12345 下5页 Last page